Ledger.Open graph →
SEC Form D · filed November 19, 2013

AILERON THERAPEUTICS INC

Offering
$30.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Christina Yeung · San Francisco, CADirectorDhruvkaran Mehta · San Francisco, CAExec · DirectorShober Holdings LLC · New York, NYDirectorJoshua Weissburg · San Francisco, CAExec · DirectorFox Point Capital Management LLC · New York, NYDirectorFox Point Performance LP · New York, NYDirectorBill Burgess · Chicago, ILDirectorGreg Buchholz · Chicago, ILDirectorChuck Teubner · Chicago, ILDirectorWilliam Elmore · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗